Skip to main content

Table 1 Baseline characteristics of type 2 diabetic patients

From: Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients

Parameters

Bitter melon 2 g/day

Bitter melon 4 g/day

Glibenclamide (5 mg/day)

 

(Group I)

(Group II)

(Group III)

N

30

31

29

Sex, M/F

21/9 (70/30)

20/11 (65/35)

18/11 (62/38)

Age (y)

51.90±10.50

52±11.40

52.20±8.70

Time since diagnosis of diabetes (yr)

0-1

22 (73)

24 (77)

20 (70)

≤2

8 (27)

7 (23)

9 (30)

BMI (Kg/m2)

25.2±1.70

25.7±2.40

25±2.20